Hypercoagulable StatesFundamental Aspects, Acquired Disorders, and Congenital Thrombophilia

Introduction
Hypercoagulable States: An Overview, J. Seghatchian and M.M. Samama
FUNDAMENTAL ASPECTS AND LABORATORY APPROACHES
Fundamental Aspects of Haemostasis/Thrombosis
Tissue Factor, Flow, and the Initiation of Coagulation, Y. Nemerson and P.B. Contino
Platelet Procoagulant Activity and Microvesicle Formation, R.F.A. Zwaal, P. Confurius, E. Smeets, and E.M. Bevers
Monocytes and Hypercoagulable States, B. Østerud
The Protein C Anticoagulant Pathway and Heparin-Antithrombin Mechanism, K.A. Bauer and R.D. Rosenberg
Study of the Prothrombotic State using Perfusion Systems, Y. Cadroy
Diagnostic Strategies and Laboratory Approaches
Laboratory Diagnosis of Hereditary Thrombophilia, F.E. Preston and M. Greaves
Diagnosis of Activation States of Circulating Platelets, M.C. Trzeciak, J.C. Bordet, and M. Dechavanne
Von Willebrand Factor in Thrombotic Disorders, M.J. Seghatchian, A.A. Halle, T. McKiernan, S. Johnson, S. Farid, and H.L. Messmore, Jr.
Critical Evaluation of Fibrinogen Assays, M.P.M. de Maat and F. Haverkate
Fibrinolysis and the Hypercoagulable State, P.J. Gaffney
Biological Markers of Acute Venous Thrombosis and Pulmonary Embolism, H. Bounameaux
Assessment of Fibrinolysis in Patients with Thrombosis-From Laboratory to Clinical Practice, J. Gram and J. Jespersen
Decreased Fibrinolytic Activity in Thrombotic Disease: An Update, B. Wiman and A. Hamsten
Drug and Blood Products Induced Hypercoagulability
Drug-Induced Hypercoagulability, M. Greaves and F.E. Preston
Drug-Dependent Platelet Activating IgG: Heparin and Streptokinase, T. Lecompte
Warfarin-Induced Hypercoagulability: Standardisation of Laboratory Aspects and Management of Skin Necrosis, M.J. Seghatchian and M.M. Samama
Paradoxical Hypercoagulability Induced by Thrombolytic Drugs, G. Helft and M.M. Samama
Update on Thrombogenicity of FIX and FXI Concentrates: Laboratory and Clinical Aspects of the Induced Hypercoagulability, J. Goudemand and M.J. Seghatchian
Artificial Surfaces and Hypercoagulability, M.J. Seghatchian
ACQUIRED DISORDERS AND CONGENITAL THROMBOPHILIA
Acquired Disorders: Epidemiology, Pathophysiological Conditions
Haemostatic Variables and Arterial Thrombotic Disease: Epidemiological Evidence, P.Y. Scarabin
Hyperlipidaemia and Blood Coagulation, M.P. Esnouf
Antiphospholipid Antibody Syndrome, D.A. Triplett
Peptide Markers in Hypercoagulability Associated with Coronary Heart Disease, G.J. Miller
Hypercoagulability and Cancer, H.C. Kwaan
Hypercoagulable States and Pregnancy, J. Bonnar
Hypercoagulability in Children and Neonates, N. Schlegel
Hypercoagulability and Diabetes Mellitus, S.C.L. Gough and C.R.M. Prentice
Hematological Disorders and Stroke, M.J. Seghatchian, T. Baglin, and M.M. Samama
Paroxysmal Nocturnal Hemoglobinuria: Pathogenesis and Clinical Manifestations of Thrombosis, T. Plesner, H. Birgens, and N.E. Hansen
Spinal Cord Injury: Pathophysiology, Hypercoagulability, and Clinical Management, D. Green and D. Chen
Hypercoagulability in Surgical Patients, G.D.O. Lowe
Hypercoagulability, Inflammatory Cytokines, Disseminated Intravascular Coagulation, and Hyperfibrinolysis, M.J. Seghatchian and M.M. Samama
Congenital Thrombophilia: Clinical Aspects, Diagnosis, and Management
Antithrombin, Its Deficiency, and Venous Thromboembolism, D.A. Lane, R.J. Olds, and S.L. Thein
Antithrombin III Deficiency: Laboratory Aspects and Clinical Management, M.J. Seghatchian, M.M. Samama, and J. Conard
Hereditary Protein C and Protein S Deficiency, I. Elalamy, J. Conard, M.H. Horellou, P. Van Dreden, and M.M. Samama
Inherited Resistance to Activated Protein C: A Single Point Mutation in the Gene for Factor V as a Major Risk Factor for Venous Thrombosis, B. Dahlback
Heparin Cofactor II, P. Sié
Hereditary Dysfibrinogenemia, Afibrinogenemia, Hypofibrinogenemia, and Thrombosis, M.M. Samama, and F. Haverkate
Plasma Fibrin Gel Architecture and Thrombotic Disorder, J.P. Collet, J. Soria, M. Mirshahi, Z. Mishal, M. Vasse, J.P. Caen, and C. Soria
Plasminogen Alteration, T. Koyama and N. Aoki
Hyperhomocysteinemia and Vascular Disease, G. Palareti, C. Legnani, and S. Coccheri
Sickle Cell Disease, E. Verdy and R. Girot
A Life-Long Hypercoagulable State in ß-Thalassemia Major Patients, A. Eldor, J. Maclouf, A. Goldfarb, R. Durst, M.C. Guillin, and E.A. Rachmilewitz
Arterial Thrombosis with Thrombocytopenia, H. Messmore, W.H. Wehrmacher, and M.J. Seghatchian
Therapeutic Aspects
The Long Search Toward Ideal Antithrombin Drugs, M. Verstraete